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The term 'retinitis pigmentosa' (RP) encompasses a group
of hereditary degenerative disorders of the retina, which
are both genetically and clinically heterogeneous. The
finding of molecular markers for certain forms of RP
potentially allows for presymptomatic and prenatal
diagnosis of a proportion of RP families. These
developments and their implications for affected South
African families are highlighted in this article.
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Retinitis pigmentosa (RP) is a heterogeneous group of
inherited degenerative retinal disorders with an incidence of
about 1:3 500 in the USA;' it is one of the more common
causes of genetic blindness. The condition may be
transmitted as an autosomal dominant, an autosomal
recessive or an X-linked trait; it may also occur sporadically
and can be a component of a number of genetic syndromes
such as Usher syndrome. Molecular studies of each genetic
type of RP have revealed that there are both allelic and non-
allelic forms of heterogeneity. However, the phenotypic and
pathological changes in all three genetic forms of RP are
essentially identical. Classically the disorder presents with
constricted visual fields early in its course, and later with
abnormal accumulation of pigmentation in the retina.
Variability in the age of onset of symptoms and, eventually,
blindness would appear to depend, at least in part, on the
mode of inheritance. Affected individuals have abnormal
electroretinograms in the early stages, and significant visual
handicap is invariably present in middle age.
X-linked recessive RP (XLRP)
XLRP is regarded as the most severe form of RP with an
incidence of about 1:20 OOO! To date, 3 distinct loci for
XLRP have been reported, mapped to the short arm of the
X-chromosome. The first of these was mapped near to the
marker, DXS7, at Xp11.3; a second at Xp21.1, close to the
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ornithine transcarbamylase gene; and a third in the region
of Xp21.2-3, near the Duchenne muscular dystrophy gene.'
Autosomal recessive RP (ARRP)
'Usher syndrome comprises classic ARRP and associated
congenital deafness.5 One form of Usher syndrome,
classified type I, characterised by profound congenital
deafness, vestibular areflexia and progressive RP from early
childhood, has been mapped to chromosome 14q (USH1a
(French)).- More recently 2 additional loci for this same form
of Usher syndrome, USH1 b (non-Acadian) and USH1 c
(French-Acadian), were mapped to chromosomes 11 q and
11 p respectively"" Usher syndrome, classified type 11, with
moderate hearing loss, normal vestibular response and
progressive RP from adolescence, has been mapped to
1q32-41 (USH2a).- However, in 20% of type 11 families.~
investigated, the condition is not linked to this chromosome
1 locus indicating that there must be another locus
(USH2b)" There are therefore at least five different genes
responsible for these two closely related phenotypes of
ARRP.
Moreover, a recent study of 126 unrelated ARRP patients'
revealed a single affected individual who is homozygous for
a nonsense base substitution in the rhodopsin gene on
chromosome 3q. This would appear to represent a null
mutation in the rhodopsin gene which causes rod photo-
receptor dysfunction and ARRP.
Autos~mal dominant RP (ADRP)
To date, four loci associated with ADRP have been mapped
to four different chromosomes, emphasising non-allelic
heterogeneity in ADRP. In 1989, an ADRP locus was found
to be linked to the rod photoreceptor gene, rhodopsin, on
chromosome 3q21-q24'O and extensive studies of this
candidate gene have revealed over 75 different mutations,
all associated with ADRP and thus demonstrating allelic
heterogeneity.
Linkage to a second candidate gene has been
demonstrated, a transmembrane protein, peripherin/RDS, on
chromosome 6p21.1-cen;" a number of different mutations
within this gene have been shown to cause ADRP. A third
locus at the pericentric region of chromosome 812 has been
inferred by linkage; however no causative gene has yet been
identified. The existence of a fourth locus associated with
ADRP, located on chromosome 7, was recently announced
at the International Retinitis Pigmentosa Association (IRPA)
meeting in Johannesburg by Shomi Bhattacharya of London
University.
Finally, exclusion of linkage to these mapped loci' in some
ADRP families provides conclusive evidence for the
existence of yet another ADRP locus."'"
The South African approach
Following a nationwide survey in 1985, Oswald et al. '5
published an overview of RP in South Africa. The
proportions of the different types of RP, according to the
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mode of inheritance, were found to be in general
accordance with those published in international studies.
Although the figures reported at that stage were recognised
as incomplete, the relative frequencies of the various forms
of RP found ·provided a perspective of the situation in South
Africa.
DNA banking
In 1990, with support from the RP Foundation of South
Africa, a DNA Banking Centre was established in the
molecular laboratory of the Department of Human Genetics,
University of Cape Town. To date, blood specimens for DNA
extraction and banking have been received from 75 RP
families, comprising 440 individuals (Table I).
Table I. Genetic categorisation of the 75 RP families from the
UCT DNA banking centre (Dec 1992)
No. of No. of affected
Inheritance pattern families individuals
Undifferentiated RP (69%)
ADRP 21 (28%) 82
ARRP 8 (11%) 11
XLRP 3 (5%) 3
Sporadic 9 (12%) 7
Indeterminate 10 (14%) 11
Syndromic RP (27%)
Usher (types I and 11) 19 28
RP-deafness-renal
dysfunction syndrome 2 3






These figures represent a mere fraction of individuals
thought to be affected in this country. According to the RP
Foundation of South Africa, which estimates that there are
some 600 RP families throughout the country, fear of
stigmatisation often prevents RP sufferers from seeking
medical assistance (C. Medefindt - personal
communication). In Table I, the term 'sporadic' has been
used to define a single RP patient with no other family
history of RP. The term 'indeterminate' refers to those
families with more than one affected individual but where
there is insufficient information to indicate typical Mendelian
patterns of inheritance.
In collaboration with the Department of National Health
and Population Development, genetics nursing sisters
throughout the country conduct home visits in order to
obtain blood specimens and collect pedigree data.
Arrangements are made for RP family members to be
examined at the Department of Ophthalmology and/or
Groote Schuur Hospital's Department of Otolaryngology (for
audiometric assessment of Usher syndrome patients) or by
other ophthalmological colleagues. A proforma .has been
compiled which clearly indicates the clinical information
required for laboratory studies, given that it recently
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emerged that precise ophthalmological information on retinal
change in RP is crucial for direction of molecular
research.'··17
One investigation, directed at correlating the molecular
genotype with the clinical phenotype, involved a study of 20
ADRP patients with different rhodopsin mutations from 6
families, where rod and cone function and rhodopsin levels
were examined.'· In this study the functional phenotypes
showed some degree of intrafamilial consistency and in
some patients with different rhodopsin mutations there were
discernible differences in the pattern of retinal dysfunction.
Molecular genetic research
In the absence of a defined biochemical defect, molecular
genetic practice is to identify and define the
subchromosomal position of a gene responsible for a
particular genetic disorder. This approach may then provide
a basis for cloning strategies and lead to the identification of
the basic mutation at the DNA level. Initially the
chromosomal positioning involves genetic linkage and
cytogenetic analysis which is then followed by physical
mapping with available molecular DNA markers and, finally,
identification of the gene product, the nature of expression
of the mutated gene and the mechanism by which it causes
the phenotype.
In 1989, molecular linkage studies of two large British RP
families revealed that one form of early onset ADRP (type I)
is associated with a marker, C17, at the D3S47 locus, which
in turn is linked to the rhodopsin gene on the long arm of
chromosome 3.'0 In South Africa, our initial focus was on
one large family with a history of early-onset ADRP.
Ancestors of this family had emigrated from England in the
early 20th century and there are now many descendants
living in the Transvaal and Natal. Molecular linkage analysis
that focused on the marker, C17, was undertaken in this
ADRP family and it was established that the disorder was
not linked to the D3S47 locus on chromosome 3 in this
particular family.'3
The next phase in the programme therefore entailed a
candidate gene approach in the search for the RP gene.
This involves testing for linkage with candidate markers from
elsewhere on the human genome, chosen because of their
role in the biochemical pathways that govern vision. Such a
candidate gene approach is expensive, time-consuming and
labour-intensive, but more cost-effective than the alternative
of a sweeping search through the genome with random
markers along each chromosome.
In the current South African RP project, candidate and
anonymous markers have been used from chromosomes 2,
3, 4, 6, 8 and 10. Despite extensive studies, tight linkage to
any recognised locus has not yet been established, but
some of the markers were uninformative in this family and
additional markers, in the same region of the chromosomes
in question, will now be used. Several dinucleotide repeat
polymorphic markers have also been obtained to render the
marker loci more informative, given the high polymorphic
information content of such markers.
An additional six smaller South African families with ADRP
are currently undw investigation and have been typed with
the rhodopsin-linked markers on chromosome 3. All of these
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families have been uninformative or have shown no clear
association with the markers used to date and are now
being studied with additional markers. As C17 is not a
suitable probe for predictive testing in all chromosome 3-
linked ADRP families, direct testing for rhodopsin mutations
is being undertaken in families where the lod score is not
less than -2,0 at 8 =0,05.'9 Once linkage has been
established in a RP family, intragenic molecular studies will
be undertaken to establish the precise mutation in that
family.
In a collaborative project involving families with the Usher
syndromes initiated in 1991, Professor Bill Kimberling of
Omaha, Nebraska, studied a total of 27 families with Usher
syndrome, type 11, including 4 families from South Africa.
Linkage was found between the disease locus and a marker
on the long arm of chromosome 11 (11 q13) in two South
African families with the Usher syndrome, type 11 (USH1 b).'
Discussion
In the light of international experience to date, it is
anticipated that each South African RP family is likely to
have a different mutation at the molecular level. Our initial
aim is to identify the defect in ADRP families with a view to
offering a service for predictive testing for the
presymptomatic gene carrier and the option of antenatal
diagnosis for RP families on request. An immediate
consequence of this would be that some forms of ADRP
could be diagnosed rapidly, even in the absence of a family
history. In addition, accurate and timely counselling could be
offered to affected patients if specific phenotypes were
found to be associated with certain mutations.
In the long term a better knowledge of the molecular
defects that cause RP may also contribute to the
understanding of the pathogenic mechanisms of the
disorder, In turn, this information may eventually facilitate the
development of an effective therapeutic approach.
The momentum of research in RP internationally was
highlighted at the recent International Retinitis Pigmentosa
Association (IRPA) congress held in Johannesburg. The
meeting provided a forum for interaction between scientists
(including cell biologists, molecular biologists, biochemists
and geneticists), ophthalmologists, nursing sisters and the
lay RP groups. It was evident from this and the previous
IRPA meeting in Dublin in 1990, that a highly motivated and
organised lay support group can indeed provide the impetus
for strongly directed research.
Given the high level of genetic heterogeneity evident in
ADRP and the fact that the disorder in most ADRP families
is not associated with the three candidate regions on 3q, 6p
and the pericentric region on 8, the most important point to
emerge from the meeting was the announcement of a fourth
candidate region for ADRP on chromosome 7 (Shomi
Bhattacharya, London University). However, the issue of
heterogeneity is still evident since some families, in which
ADRP was not linked to 3, 6 or 8, were also not linked to
chromosome 7 (Peter Humphries, Dublin). The likelihood of
a fifth locus for ADRP underlines the extensive genetic
heterogeneity in this group of hereditary degenerative
disorders of the retina.
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of all RP families in South Africa. Thanks go to Mss. Marlene
Goedhart, Michelle Babaya and Rene Goliath, the genetics
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